Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice

C Antonopoulos1, M Cumberbatch, R J Dearman

  • 1Center for Dermatology, Department of Medicine, University College London, London, United Kingdom.

Insights

Caspase-1 deficiency impairs Langerhans cell (LC) migration, a key step in skin immunity. Inhibiting caspase-1 blocks LC migration and contact hypersensitivity, suggesting it as a therapeutic target.

Area of Science:

  • Immunology
  • Dermatology
  • Cell Biology

Background:

  • Langerhans cell (LC) migration is crucial for initiating skin immune responses.
  • Tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) are known regulators of LC migration.
  • The role of caspase-1 in processing IL-1 alpha and its impact on LC migration remained unclear.

Purpose of the Study:

  • To investigate the role of caspase-1 in regulating Langerhans cell migration from the epidermis to draining lymph nodes.
  • To determine if caspase-1 activity is essential for TNF-alpha-induced LC migration.
  • To assess the functional consequences of impaired LC migration on contact hypersensitivity.

Main Methods:

  • Utilized wild-type (WT) and caspase-1-deficient mice.
  • Applied contact allergens (2,4-dinitrofluorobenzine, oxazolone) to induce LC migration.
  • Administered TNF-alpha and IL-1 beta intradermally to assess their effects on LC migration.
  • Used caspase-1 inhibitor (Ac-YVAD-cmk) in vitro (organ culture) and in vivo.

Main Results:

  • Caspase-1-deficient mice showed a lack of epidermal LC reduction upon allergen exposure.
  • TNF-alpha failed to induce LC migration in caspase-1-deficient mice, unlike in WT mice.
  • Contact hypersensitivity responses were significantly inhibited in caspase-1-deficient mice.
  • Caspase-1 inhibition blocked LC migration in vitro and in vivo, reducing contact hypersensitivity.

Conclusions:

  • Caspase-1 plays a critical role in regulating epidermal Langerhans cell migration.
  • Caspase-1 activity is necessary for TNF-alpha-mediated LC migration.
  • Targeting caspase-1 with inhibitors presents a potential therapeutic strategy for modulating skin immune responses.